Staining of tumor xenografts by this antibody showed that the level of p-HRS was much lower in the group of tumor tissues treated with BVD-523, an ERK inhibitor used in clinical trials (Supplementary Fig. 1c). The gene discussed is MAPK1; the disease is neoplasm.